Institute for Technology Assessment

Dr. Gazelle is Professor of Radiology at Harvard Medical School and Professor in the Department of Health Policy and Management at the Harvard School of Public Health.  He serves as Director of the MGH Institute for Technology Assessment and the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training.  He is also Vice Chair for Faculty Development and Associate Vice-Chair for Research in the MGH Department of Radiology. 

Dr. Gazelle received his BA from Dartmouth College, and his MD from Case Western Reserve University School of Medicine.  He completed a Radiology residency at University Hospitals of Cleveland, where he also served as Chief Resident.  Following residency, he completed a fellowship in Abdominal Imaging and Interventional Radiology at the Massachusetts General Hospital, and then joined the faculty at the MGH in the Division of Abdominal Imaging and Interventional Radiology.  In 1996, he received an MPH from the Harvard School of Public Health, where he majored in Health Care Management.  In 1999, he received a PhD in Health Policy from Harvard University. 

Dr. Gazelle has been President of the Association of University Radiologists, the Radiology Research Alliance and the New England Roentgen Ray Society.  He has also been Chair of the American College of Radiology Commission on Research and Technology Assessment, the RSNA Research Development Committee and Director of Partners Radiology.  He currently serves on the RSNA R&E Foundation Board of Trustees.  Dr. Gazelle is nationally and internationally known for his research evaluating the benefits, costs, and appropriate use of new medical technologies.  Locally, he has lead efforts at Partners HealthCare System to improve quality and safety in radiology and to develop approaches that can be used to measure and document performance improvement.  Dr. Gazelle has authored more than 200 scientific articles, published 2 textbooks and presented numerous papers, lectures, and workshops nationally and internationally. 

• Tramontano, A., Cipriano, L., Kong, C. Y., Shepard, J.-A., Lanuti, M., Gazelle, G. S. & McMahon, P. M. (2013). Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.. AJR Am J Roentgenol, 200(5), 1020-1027. [Online version]
• Nolte, J., Neumann, T., Manne, J. M., Lo, J., Neumann, A., Mostardt, S., Abbara, S., Hoffmann, U., Brady, T. J., Wasem, J., Grinspoon, S. K., Gazelle, G. S. & Göhler, A. (2013). Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men.. Eur J Prev Cardiol. [Online version]
• Chubiz, J., Lee, J., Gilmore, M., Kong, C. Y., Lowry, K., Halpern, E. F., McMahon, P. M., Ryan, P. D. & Gazelle, G. S. (2013). Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.. Cancer, 119(6), 1266-1276. [Online version]
• Pandharipande, P., Eisenberg, J., Lee, R. J., Gilmore, M., Turan, E., Singh, S., Kalra, M. K., Liu, B., Kong, C. Y. & Gazelle, G. S. (2013). Patients with Testicular Cancer Undergoing CT Surveillance Demonstrate a Pitfall of Radiation-induced Cancer Risk Estimates: The Timing Paradox.. Radiology, 266(3), 896-904. [Online version]
• Knudsen, A., Hur, C., Gazelle, G. S., Schrag, D., McFarland, E. G. & Kuntz, K. M. (2012). Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.. Ann Intern Med, 157(9), 611-620. [Online version]